₹498.55
₹-1.85 (-0.37%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹15,885 Cr
P/E
85.80
ROE
6.58%
ROCE
9.75%
About Dr Agarwals Health Care Ltd
Dr Agarwal's Health Care is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.
Founded
2010
CEO
Amar Agarwal.
Employees
3,371
HQ
Chennai, India
About Dr Agarwals Health Care Ltd
Dr Agarwal's Health Care is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.
Founded:2010
CEO:Amar Agarwal.
Employees:3,371
HQ:Chennai, India
Finished Products
1Income from Surgeries
₹718.13Cr2Sale of Services
₹673.81Cr3Sale of Products
₹358.60Cr4Income from Treatments and Inv
₹75.43Cr5Income from Consultation
₹48.14Cr6Other Operating Income
₹4.84CrRaw Materials
1Purchases of Stock-in-Trade
₹81.55Cr2Contact Lens and Ac
₹52.13Cr3Opticals
₹48.21Cr4Pharmaceutical Products
₹7.80CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹568
52W Low
₹401
Volume265.31K
Avg VolumeN/A
Beta0.28
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
85.80x
Valuation
P/B Ratio
7.84x
Valuation
EPS
₹5.84
Valuation
Dividend Yield
0.00%
Valuation
ROE
6.58%
Profitability
ROCE
9.75%
Profitability
Revenue by Segment
Contribution & growth by business line
Eye care related sales and servicesRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
89.9%
International
10.1%
Within India89.9%
Outside India10.1%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.53x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
18.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.